Brain metastases in lung cancer: Key abstracts from the 2019 ASCO Annual Meeting
The ASCO Annual Meeting 2019 program included a number of studies that provide new insights into, and potential avenues for treating, brain metastases (BMs) in NSCLC patients, particularly in the EGFR-mutant population. Here we provide digestible and downloadable summaries of these latest updates as a resource for HCPs managing NSCLC patients with BMs. The slides cover radiotherapy, immunology, pathology, and markers.
Click the image below to download the slide set:
These slides were made possible by independent educational funding provided by AstraZeneca.